Europe — EMA

Olmetec (Olmesartan Medoxomil)

Olmesartan medoxomil, the active ingredient in Olmetec, is an angiotensin II receptor blocker presented as a tablet for oral use. It is employed in the management of hypertension in adult patients.

Olmesartan Medoxomil

Request sourcing

Pack/s

What is Olmesartan Medoxomil?

Olmesartan medoxomil, the active ingredient in Olmetec, is an angiotensin II receptor blocker presented as a tablet for oral use. It is employed in the management of hypertension in adult patients. GNH USA supplies Olmetec as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Olmetec as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

What is Olmesartan Medoxomil used for?

Olmesartan medoxomil is used to treat conditions within the renin‑angiotensin system that affect blood pressure control.

- Hypertension: helps lower systolic and diastolic blood pressure to reduce cardiovascular risk. - Heart failure: used as part of combination therapy to improve symptoms and outcomes. - Diabetic nephropathy: provides renal protection by controlling systemic pressure. - Post‑myocardial infarction: aids in long‑term blood pressure management after an MI. - Stroke prevention: contributes to secondary prevention by maintaining target blood pressure levels.

What are the side effects of Olmesartan Medoxomil?

Olmesartan medoxomil … … … … … … …

What precautions apply to Olmesartan Medoxomil?

Olmesartan …

What does Olmesartan Medoxomil interact with?

…

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →